Home » Optimizing Treatment for Medication Adherence in Schizophrenia
Optimizing Treatment for Medication Adherence in Schizophrenia
This CME activity is sponsored by Med Learning Group. This CNE activity is sponsored by Ultimate Medical Academy/CCM.
This activity is supported by an educational grant from Eli Lilly & Company
Specialty: Psychiatric Medicine
Release date: November 29, 2013
Valid through: November 28, 2014
Appropriate educational initiatives aimed at understanding evolving roles of atypical antipsychotics, developing treatment plans that improve adherence and outcomes for patients with schizophrenia, quantifying the impact of non-adherence on quality of life, and discussing collaborative efforts between patients and caregivers will support effective care for those with schizophrenia. As educators, we have the opportunity to improve on our already high standards of care in schizophrenia in order to enhance patient outcomes and quality of life for this long-term condition.